Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO

Published by
ACN Newswire

Hoboken, NJ, Rostock & Berlin, Germany, Jan 12, 2022 – (ACN Newswire) – Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers people to take control of their health is pleased to announce that our Founder, Prof. Dr. Arndt Rolfs, a multi-entrepreneur in biotech and former CEO of several innovative biotech companies, including Nasdaq-listed company CENTOGENE, has been appointed as the Chief Executive Officer of Arcensus GmbH. Prof. Rolfs has succeeded the role from Mr. Michael Schlenk and assumed the responsibilities of CEO on January 01, 2022. We are very gratefu…

Read More

See also  ALFRED TECHNOLOGIES' WINE & SPIRITS INVENTORY AND MANAGEMENT SOLUTIONS ARE NOW AVAILABLE IN THE U.S.

Leave a Reply